Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PDSG --SOLD--

Unlikely we'll see much if any of a return on our "$10M plus" investement on Crossflo. Essentially, PTSC gave Nonaka the company in return for a royalty on future revenues for the next 3 years per the 10q.

Based on PDSG's revenue generation of late, unless Nonaka has $20M contract up his sleeve, that's $10M plus that our crew flushed down the toilet.

Though, just like the dividends for warrant holders, I wonder if the Crossflo acquisition wasn't always intended to be just a "legal" mechanism and surefire way to transfer large sums of money from the PTSC treasury to certain interests, rather than be at risk with the rest of the shareholders. Is it a rigged game? Obviously to a certain extent it always is. $9K share purchases don't really do much to change that IMO.

Share
New Message
Please login to post a reply